Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression

Haematologica

Volumn 93, Issue 12, 2008, Pages 1822-1828

  Gagyi, Éva ^a   Balogh, Zsófia ^a   Bödör, Csaba ^a   Timár, Botond ^a   Reiniger, Lilla ^a   Deák, Linda ^a   Csomor, Judit ^a   Csernus, Balázs ^a   Szepesi, Ágota ^a   Matolcsy, András ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Aberrant somatic hypermutation; Activation induced cytidine deaminase; Follicular lymphoma; Somatic hypermutation

Indexed keywords

CYTIDINE DEAMINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; PROTEIN EXPRESSION;

ADULT; AGED; CYCLIN D1; FEMALE; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 57349114233     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13239     Document Type: Article

References (30)

1. Jaffe ES, Harris NL, Stein H, Wardiman JW. Follicular lymphoma. In: Banks PM, Warnke RA, eds. Pathology and Genetics of Tumours of Haemopoetic and Lymphoid Tissues World Health Organization Classification of Tumours. Lyon: IARC Press; 2001. p. 162-7.
2. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989;57:79-88.
3. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-3.
4. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-2.
5. Hardianti MS, Tatsumi E, Syampurnawati M, Furuta K, Saigo K, Nakamachi Y, et al. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL. Leukemia 2004;18:826-31.
6. Natkunam Y. The biology of the germinal center. Hematology Am Soc Hematol Educ Program 2007;2007:210-5.
7. Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 1998;95:11816-21.
8. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001;412:341-6.
9. Bende RJ, Smit LA, van Noesel CJ. Molecular pathways in follicular lymphoma. Leukemia 2007;21:18-29.
10. Bosga-Bouwer AG, van Imhoff GW, Boonstra R, van der Veen A, Haralambieva E, van den Berg A, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood 2003;101:1149-54.
11. Godon A, Moreau A, Talmant P, Baranger-Papot L, Genevieve F, Milpied N, et al. Is t(14;18)(q32;q21) a constant finding in follicular lymphoma? An interphase FISH study on 63 patients. Leukemia 2003;17:255-9.
12. Guo Y, Karube K, Kawano R, Yamaguchi T, Suzumiya J, Huang GS, et al. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia 2005;19:1058-63.
13. Horsman DE, Okamoto I, Ludkovski O, Le N, Harder L, Gesk S, et al. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes. Br J Haematol 2003;120:424-33.
14. Ott G, Katzenberger T, Lohr A, Kindelberger S, Rudiger T, Wilhelm M, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002;99:3806-12.
15. Bosga-Bouwer AG, van den Berg A, Haralambieva E, de Jong D, Boonstra R, Kluin P, et al. Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma? Hum Pathol 2006;37:528-33.
16. Guo Y, Karube K, Kawano R, Suzumiya J, Takeshita M, Kikuchi M, et al. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression. Pathol Int 2007;57:148-52.
17. Jardin F, Gaulard P, Buchonnet G, Contentin N, Lepretre S, Lenain P, et al. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics. Leukemia 2002;16:2309-17.
18. Tagawa H, Karube K, Guo Y, Takeshita M, Kikuchi M, Morishima Y, et al. Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma. Leukemia 2007; 21:2549-51.
19. Piccaluga PP, Califano A, Klein U, Agostinelli C, Bellosillo B, Gimeno E, et al. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas. Haematologica 2008;93:1033-8.
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
21. Chang B, Casali P. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 1994;15:367-73.
22. Lossos IS, Tibshirani R, Narasimhan B, Levy R. The inference of antigen selection on Ig genes. J Immunol 2000;165:5122-6.
23. Gaidano G, Pasqualucci L, Capello D, Berra E, Deambrogi C, Rossi D, et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood 2003;102:1833-41.
24. Aster JC, Longtine JA. Detection of BCL2 rearrangements in follicular lymphoma. Am J Pathol 2002;160:759-63.
25. Schraders M, de Jong D, Kluin P, Groenen P, van Krieken H. Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation. J Pathol 2005;205:329-35.
26. Zelenetz AD, Chen TT, Levy R. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med 1992;176:1137-48.
27. Zha H, Raffeld M, Charboneau L, Pittaluga S, Kwak LW, Petricoin E 3rd, et al. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab Invest 2004;84:235-44.
28. Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE, et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003;101:3574-80.
29. Halldórsdóttir AM, Frühwirth M, Deutsch A, Aigelsreiter A, Beham-Schmid C, Agnarsson BA, et al. Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma. Leuk Res 2008;32:1015-21.
30. Rossi D, Berra E, Cerri M, Deambrogi C, Barbieri C, Franceschetti S, et al. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. Haematologica 2006;91:1405-9.